A detailed history of Black Rock Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,905,156 shares of PCRX stock, worth $224 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,905,156
Previous 8,114,251 2.58%
Holding current value
$224 Million
Previous $274 Million 15.63%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$27.7 - $35.48 $5.79 Million - $7.42 Million
-209,095 Reduced 2.58%
7,905,156 $231 Million
Q4 2023

Feb 13, 2024

BUY
$26.32 - $34.31 $16 Million - $20.8 Million
607,254 Added 8.09%
8,114,251 $274 Million
Q3 2023

Nov 13, 2023

BUY
$30.68 - $40.09 $783,199 - $1.02 Million
25,528 Added 0.34%
7,506,997 $230 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $47.5 $1.15 Million - $1.52 Million
-31,959 Reduced 0.43%
7,481,469 $300 Million
Q1 2023

May 12, 2023

BUY
$35.53 - $43.38 $9.31 Million - $11.4 Million
261,983 Added 3.61%
7,513,428 $307 Million
Q4 2022

Feb 13, 2023

BUY
$38.19 - $57.45 $3.7 Million - $5.57 Million
96,867 Added 1.35%
7,251,445 $280 Million
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $2.23 Million - $2.56 Million
43,517 Added 0.61%
7,154,578 $381 Million
Q2 2022

Aug 12, 2022

BUY
$51.49 - $81.64 $7.23 Million - $11.5 Million
140,506 Added 2.02%
7,111,061 $415 Million
Q1 2022

May 12, 2022

BUY
$60.03 - $76.49 $8.95 Million - $11.4 Million
149,037 Added 2.18%
6,970,555 $532 Million
Q4 2021

Feb 10, 2022

BUY
$47.97 - $62.21 $6.03 Million - $7.82 Million
125,626 Added 1.88%
6,821,518 $410 Million
Q3 2021

Nov 09, 2021

BUY
$54.64 - $61.3 $2.01 Million - $2.26 Million
36,812 Added 0.55%
6,695,892 $375 Million
Q2 2021

Aug 11, 2021

BUY
$59.18 - $69.99 $394 Million - $466 Million
6,659,080 New
6,659,080 $404 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.3B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.